Lara Longpre
Chief Development Officer, Mirum Pharmaceuticals.
Companies
- Mirum PharmaceuticalsChief Development Officer Jul 17, 2019 to Mar 18, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mirum Pharmaceuticals MIRM104,407 shares2$8.6M at $82.39Feb 2, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 2, 2024Sold 847 shares at $26.19 of Mirum Pharmaceuticals2
- Jan 8, 2024Sold 1,019 shares at $28.04 of Mirum Pharmaceuticals3
- Nov 10, 2023Granted 434 shares at $22.29 of Mirum Pharmaceuticals4
- Jul 3, 2023Sold 1,004 shares at $25.65 of Mirum Pharmaceuticals5
- May 10, 2023Granted 684 shares at $16.92 of Mirum Pharmaceuticals6
- Jan 31, 2023Granted 9,625 shares of Mirum Pharmaceuticals7
- Jan 9, 2023Sold 1,003 shares at $20.62 of Mirum Pharmaceuticals8
- Nov 10, 2022Granted 82 shares at $17.05 of Mirum Pharmaceuticals9
- May 10, 2022Granted 1,454 shares at $13.57 of Mirum Pharmaceuticals10
- Jan 6, 2022Granted 10,000 shares of Mirum Pharmaceuticals11
- Nov 10, 2021Granted 753 shares at $13.52 of Mirum Pharmaceuticals12
- Oct 1, 2021Sold 961 shares at $19.26 of Mirum Pharmaceuticals13
- Sep 29, 2021Granted 8,125 shares of Mirum Pharmaceuticals13
- Sep 10, 2019Bought 965 shares at $10.64 of Mirum Pharmaceuticals8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 9, 2024
- 4SEC EDGARForm 4 filed Nov 15, 2023
- 5SEC EDGARForm 4 filed Jul 5, 2023
- 6SEC EDGARForm 4 filed May 19, 2023
- 7SEC EDGARForm 4 filed Feb 2, 2023
- 8SEC EDGARForm 4 filed Mar 18, 2024
- 9SEC EDGARForm 4 filed Nov 14, 2022
- 10SEC EDGARForm 4 filed May 12, 2022
- 11SEC EDGARForm 4 filed Jan 7, 2022
- 12SEC EDGARForm 4 filed Nov 15, 2021
- 13SEC EDGARForm 4 filed Oct 1, 2021